High-dose magnesium infusion for severe asthma in the emergency room
Part of Lungs & breathing clinical trials.
This trial tests whether giving a higher dose of magnesium (given as an IV drip) works better than the standard dose for treating a severe asthma attack in the emergency room. It aims to see if the higher dose helps you breathe easier sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and have a known asthma diagnosis.
- You are currently having an asthma attack, with symptoms like shortness of breath, rapid breathing, wheezing, chest tightness, or cough.
- You do not need a breathing tube at the time you first arrive at the emergency room.
- You do not have dangerously high magnesium levels in your blood.
- You do not have a history of allergy to magnesium sulfate, or conditions like myasthenia gravis or other nerve/muscle diseases.
- You are not pregnant, do not have severe kidney disease, heart block, or suspected COVID-19 or tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving magnesium sulfate through an IV helps children with moderate to severe asthma attacks in the emergency department. If your child is between 2 and 17 years old and still has trouble breathing after three puffs of standard asthma medicine, this study may be an option.
This trial tests whether giving magnesium sulfate through an IV early in the emergency room helps children aged 5–17 who are having a moderate asthma attack. It aims to improve breathing and reduce the need for hospital stays.
This study tests if giving magnesium sulfate (a mineral supplement) helps children with asthma or bronchiolitis breathe better. It is for children aged 1 month to under 18 years who have these conditions.
This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.
This trial tests whether giving a higher dose of magnesium (4 grams) compared to a lower dose (2 grams) or a placebo can help control a fast heart rate during atrial fibrillation. It may help patients who are already receiving diltiazem.
This trial tests whether a magnesium infusion can better control pain in adults who have serious injuries and need intensive care. It compares magnesium as part of pain treatment to standard pain care to see if pain improves and stays controlled.
Hear when a new Emergency Department trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.